GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OSTO:VIVE) » Definitions » Total Equity

Vivesto AB (OSTO:VIVE) Total Equity : kr168.89 Mil (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Vivesto AB Total Equity?

Vivesto AB's total equity for the quarter that ended in Sep. 2024 was kr168.89 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Vivesto AB Total Equity Historical Data

The historical data trend for Vivesto AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivesto AB Total Equity Chart

Vivesto AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 383.50 819.39 549.71 326.16 197.80

Vivesto AB Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 261.17 197.80 189.37 179.08 168.89

Vivesto AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Vivesto AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=220.673-22.874
=197.80

Vivesto AB's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=184.531-15.642
=168.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivesto AB Total Equity Related Terms

Thank you for viewing the detailed overview of Vivesto AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivesto AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OSTO:VIVE) » Definitions » Total Equity
Comparable Companies
OSTO:TOL OSTO:ERMA XSAT:ACUC OSTO:NEWBRY OSTO:KLAR XSAT:ODI XSAT:PMED XSAT:DANCAN OSTO:GABA OSTO:NANEXA ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
OASMY:USA OMAX:Germany
Address
Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Website
https://www.vivesto.com
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.